Research is exploring the metabolic adaptations of immunosuppressive cells in cancer, investigating mechanisms and potential therapeutic targets. Studies are examining the complex interactions between cancer cells, immune cells, and other components of the tumor microenvironment, including metabolic reprogramming and rewiring. The findings may have implications for the development of new cancer therapies, although the specific details and outcomes of these studies are not yet clear.